Adenosine A2A receptors are upregulated in peripheral blood mononuclear cells from atrial fibrillation patients

dc.contributor.authorGodoy-Marín, Héctor
dc.contributor.authorDuroux, Romain
dc.contributor.authorJacobson, Kenneth A.
dc.contributor.authorSoler Prat, Concepció
dc.contributor.authorColino-Lage, Hildegard
dc.contributor.authorJiménez-Sábado, Veronica
dc.contributor.authorMontiel, José
dc.contributor.authorHove-Madsen, Leif
dc.contributor.authorCiruela Alférez, Francisco
dc.date.accessioned2021-04-23T15:56:29Z
dc.date.available2021-04-23T15:56:29Z
dc.date.issued2021-03-27
dc.date.updated2021-04-23T15:56:30Z
dc.description.abstractAtrial fibrillation (AF) is the most common form of cardiac arrhythmia seen in clinical practice. While some clinical parameters may predict the transition from paroxysmal to persistent AF, the molecular mechanisms behind the AF perpetuation are poorly understood. Thus, oxidative stress, calcium overload and inflammation, among others, are believed to be involved in AF-induced atrial remodelling. Interestingly, adenosine and its receptors have also been related to AF development and perpetuation. Here, we investigated the expression of adenosine A2A receptor (A2AR) both in right atrium biopsies and peripheral blood mononuclear cells (PBMCs) from non-dilated sinus rhythm (ndSR), dilated sinus rhythm (dSR) and AF patients. In addition, plasma adenosine content and adenosine deaminase (ADA) activity in these subjects were also determined. Our results revealed increased A2AR expression in the right atrium from AF patients, as previously described. Interestingly, increased levels of adenosine content and reduced ADA activity in plasma from AF patients were detected. An increase was observed when A2AR expression was assessed in PBMCs from AF subjects. Importantly, a positive correlation (P=0.001) between A2AR expression in the right atrium and PBMCs was observed. Overall, these results highlight the importance of the A2AR in AF and suggest that the evaluation of this receptor in PBMCs may be potentially be useful in monitoring disease severity and the efficacy of pharmacological treatments in AF patients.
dc.format.extent12 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec711533
dc.identifier.issn1661-6596
dc.identifier.pmid33801676
dc.identifier.urihttps://hdl.handle.net/2445/176685
dc.language.isoeng
dc.publisherMDPI
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.3390/ijms22073467
dc.relation.ispartofInternational Journal of Molecular Sciences, 2021, vol. 22, num. 7, p. 3467
dc.relation.urihttps://doi.org/10.3390/ijms22073467
dc.rightscc-by (c) Godoy-Marín, Héctor et al., 2021
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es
dc.sourceArticles publicats en revistes (Patologia i Terapèutica Experimental)
dc.subject.classificationAdenosina
dc.subject.classificationFibril·lació auricular
dc.subject.classificationNuclis cel·lulars
dc.subject.otherAdenosine
dc.subject.otherAtrial fibrillation
dc.subject.otherCell nuclei
dc.titleAdenosine A2A receptors are upregulated in peripheral blood mononuclear cells from atrial fibrillation patients
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
711533.pdf
Mida:
2.9 MB
Format:
Adobe Portable Document Format